Balyasny Asset Management
RYZB

Balyasny Asset Management’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Balyasny Asset Management’s Portfolio RYZB Stock Details RYZB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-539,793
Closed -$33.6M – 3253
2023
Q4 		$33.6M Buy
+539,793
New +$13.4M 0.06% 398

Balyasny Asset Management's RYZB Position: Q1 2024 in Review

Balyasny Asset Management sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 539,793 shares — an estimated $33.6M sold.

Balyasny Asset Management first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $33.6M in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

  • Balyasny Asset Management reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Balyasny Asset Management sold 539,793 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $33.6M.
  • Balyasny Asset Management first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
  • Balyasny Asset Management's RayzeBio, Inc. Common Stock position peaked at $33.6M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Balyasny Asset Management's 13F filing for Q1 2024, filed 13 May 2024.